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Cisplatin is cis-diamminedichloroplatinum (II) of chemical formula, Pt(NH3)Cl2, 
abbreviated as cis-DDP and known commercially as platinol. It is used widely as an 
anticancer drug for various types of cancer, ever since its discovery two centuries 
ago and has become a target of extensive researches1-5. Transplatin, trans-DDP on 
the other hand, is found to be less or ineffective to treat cancers. Cisplatin is known 
to interact mainly with the N(7) nitrogen of guanine in nucleic acids, after a water 
molecule takes away one of the chlorines by hydrolysis. This initiates the damage of 
nucleic acids and eventually leads to apoptosis1. However the way how this happens 
and why transplatin is less effective is not completely clear. Here the author brings 
some new insights, using the precise structures of these molecules at the atomic 
level, how cisplatin can interact with the nitrogen of guanine and adenine and rupture 
the hydrogen bonding in the Watson Crick base pairs and damage the structure of 
DNA. It is hoped that the results presented here will contribute to a better atomistic 
insight into the structure, bonding and feasibility of the biochemical reactions 
involving these compounds and their derivates4 for the alleviation of cancer. 
    Cisplatin, Pt(NH3)Cl2, is nearly a square planar inorganic coordination compound. 
The crystal structure6 of cisplatin, shows that the Pt-Cl and Pt-N bondlengths are 
2.33(0.01) Å and 2.01(0.04) Å respectively. Theoretical estimates7 give 2.34 Å and 
2.09 Å, respectively for Pt-Cl and Pt-N bond lengths, which are close to the above6
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2experimental values. Here it is pointed out that these bond lengths, in fact, are sums 
of the covalent radii of the adjacent atoms, a general rule found valid for many 
inorganic, organic and biological compounds8-10. Thus, the bond lengths, d(Pt-Cl) = 
2.34 Å and d(Pt-N) = 2.09 Å, as sums of the covalent radii, Rcov(Pt) = 1.39 Å, 
Rcov(Cl) = 0.95 Å and Rcov(Nsb.) = 0.70 Å, which are halves of the respective bond 
lengths11,12, d(Pt-Pt), d(Cl-Cl) and d(N-N)sb.. The covalent radii of the atoms in 
Pt(NH3)Cl2 drawn to scale are given in Fig. 1a and the atomic structures of cis-DDP 
and trans-DDP are shown in Figs. 1b and 1c respectively.   
    The action of cisplatin as an anticancer agent is attributed to its binding mainly 
with the N(7) of guanine1-5 which is one of the two purines forming the Watson 
Crick base pairs. In Fig. 2 are given the covalent radii of the atoms which account for 
all the bond lengths in nucleic acids8,9, which are used in Fig. 3 for the atomic 
structures along with all the bondings in adenine (A), thymine (T), cytosine (C) and 
guanine (G) constituting the Watson Crick base pairs8,9. The binding of cisplatin to 
the nitrogen Nd.b.(7) of guanine is facilitated by the hydrolysis1-5 of the chlorine 
bound to platinum as shown in the cytotoxic pathway in3. The Cl probably first forms 
a hydrogen bond13 with a water molecule prior to detachment from Pt. The atomic 
structure of the resulting guanine-PtCl(NH3)2 complex is shown in Fig. 4.    
    While the first chlorine binds to guanine, the second chlorine of cis-DDP can also 
removed similarly by another water molecule and the guanine-Pt(NH3)2 complex 
binds to a second available nitrogen of a nearby base pair. Although cisplatin is 
known to interact mainly with the Nd.b.(7) of guanine, other reactive nitrogens in the 
Watson -Crick base pairs like Nd.b.(3) of adenine are also vulnerable (see Fig. 3).  
The disposition of these nitrogens of guanine and adenine in DNA is shown in Fig. 
5a in the molecular structure at the atomic scale of DNA as given in8,9. The lengths 
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3of the hydrogen bonds connecting A with T and C with G in the Watson-Crick base 
pairs are interpreted in13. Since the Nd.b.(3) nitrogen of adenine (A) is closest to the 
Nd.b.(7) of guanine (G) for bond formation with Pt at a distance of about 2 Å and is 
sterically favorably diposed at an angle close to ~900 vacated by the two Cl atoms of 
cis-DDP, the [= Pt(NH3)2] complex bonds with the Nd.b.(7) of guanine and Nd.b.(3) of 
adenine as shown in Fig. 5b. It can be seen on comparing Fig. 5b with Fig. 5a of the 
intact DNA, that in the former, the hydrogen bond of the Watson-Crick base pair 
ruptures and causes damage to the structure of DNA. Also, if the Pt forms covalent 
bonds with the Nd.b.(7) of guanine and Nd.b.(3) of adenine, the Nd.b. will acquire the 
single bond radius, Ns.b. which is larger (see Fig. 2). The data14 on Pt-N(7)(guanine) 
bond lengths are around 2.51 to 2.16 Å at 20 and 61 % occupancy respectively, 
which shows that they decrease from a longer distance of coordination bond length to 
probably a single bond length, d(Pt-Ns.b.) = 2.09 Å at higher occupancy. In the latter 
case, the bonding of the Ns.b.(7) with the adjacent atoms in guanine and similarly of 
Ns.b.(3) in adenine will also change causing further strains in the structures of the two 
purines. Thus cisplatin causes extensive structural damage to DNA. 
    In transplatin (see Fig 1c), the two chlorines are 1800 apart and hence cannot bind 
to N(7) and N(3) of guanine and adenine like cis-DDP. This could be a reason why 
trans-DDP is not as effective an anticancer agent as cisplatin. 
    To summarize, presented here for the first time are structures drawn to scale at the 
atomic level of cis-DDP and trans-DDP and of the binding of cisplatin to guanine 
and adenine of the Watson-Crick base pairs in DNA and the subsequent damage of 
the structure in DNA. 
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Figure legends: 
Figure 1a-c  Structures of cis- and transplatins. a) Atomic covalent radii, Rcov of Cl 
(greenish yellow), Pt (white), nitrogen (blue) and H (green); subscript s.b.: single 
bond) radii.  b) and c) Atomic structures of cis- and transplatins respectively. All 
bond lengths are sums of Rcov of adjacent atoms. In b): cisplatin (area of the rectangle 
represented by the dotted lines: 5.65 x 5.8 Å = 32.8 Å2 = 0.328 nm2) and in c): 
transplatin (area of the square represented by the dotted lines: 5.8 x 5.8 Å = 33.6 Å2
= 0.336 nm2).  
Figure 2 Covalent radii Rcov of the atoms in DNA. Subscripts, s.b.: single bond, g.b.: 
graphitic bond, d.b.: double bond. 
Figure 3 Atomic structures of the purines and pyrimidines of the Watson-Crick base 
pairs in DNA. Uracil (U) replaces Thymine (T) in RNA. All bond lengths are sums 
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6of the covalent radii of the adjacent atoms (given in Fig. 2). Base pairing occurs 
when hydrogen bonds connect T with A, and C with G along the broken lines. See8,9.
Figure 4 Guanine-cisplatin complex. One Cl of CDDP is aquated and removed by 
water enabling Pt to bind with the N(7) of guanine.
Figure 5a,b Atomic structure of DNA a) before and b) after damage by cis-platin. 
All bond lengths are sums of the radii of the adjacent atoms given in Fig. 2. See8,9.
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Fig. 1a-c 
a)      Cls.b.     Pts.b.    Ns.b.    Hs.b.    
Rcov: 0.95      1.39    0.70    0.37 (Å) 
b) Cisplatin c) Transplatin 
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Fig. 2 
        Cs.b.       Cg.b.      Cd.b.      Ns.b.     Nd.b.    Hs.b.  Os.b.     Od.b.      Pd.b.
Rcov: 0.77      0.72      0.67     0.70     0.62   0.37   0.67    0.60      0.92 (Å) 
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Fig. 3 
Cytosine (C) 
N(1)   N(3) 
C(6)
C(4)
Thymine (T) 
N(1) N(3) 
C(6) C(4) 
Adenine (A)
N(1) C(5)   N(7) 
N(9)
C(2)    N(3) 
Guanine (G)
 H + 
OH(1’) (of 
sugar) = 
H2O 
C(2)    N(3)    N(9) bonds 
with C(1’) of sugar 
C(5)   N(7) 
N(1)
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Fig. 4 
Guanine
Cisplatin 
Cl (H2O)
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